CAS 289499-45-2
:Canertinib dihydrochloride
Description:
Canertinib dihydrochloride is a small molecule tyrosine kinase inhibitor primarily used in cancer therapy. It specifically targets the epidermal growth factor receptor (EGFR) and is known for its potential efficacy against various solid tumors, particularly those with EGFR mutations. The dihydrochloride form indicates that the compound is a salt, enhancing its solubility and stability in pharmaceutical formulations. Canertinib is characterized by its ability to inhibit cell proliferation and induce apoptosis in cancer cells by blocking the signaling pathways associated with tumor growth and survival. Its chemical structure includes a quinazoline core, which is common among EGFR inhibitors. The compound is typically administered orally and has been studied in clinical trials for its effectiveness in treating conditions such as non-small cell lung cancer and head and neck cancers. As with many targeted therapies, potential side effects may include skin rash, diarrhea, and liver enzyme elevation, necessitating careful monitoring during treatment.
Formula:C24H25ClFN5O3·2ClH
InChI:InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H
InChI key:InChIKey=JZZFDCXSFTVOJY-UHFFFAOYSA-N
SMILES:N(C=1C2=C(C=C(OCCCN3CCOCC3)C(NC(C=C)=O)=C2)N=CN1)C4=CC(Cl)=C(F)C=C4.Cl
Synonyms:- 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, dihydrochloride
- 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2)
- Canertinib 2HCl
- Ci 1033
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[2-(morpholin-4-yl)ethoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
- Pd 183805
- Canertinib dihydrochloride
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2)
CAS:Formula:C24H26Cl2FN5O3Purity:98%Color and Shape:SolidMolecular weight:522.3993Canertinib Dihydrochloride
CAS:<p>Canertinib Dihydrochloride</p>Purity:98%Molecular weight:558.86g/mol2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2)
CAS:Purity:98%Molecular weight:558.859985351563Canertinib dihydrochloride
CAS:<p>Canertinib dihydrochloride (PD-183805 dihydrochloride) is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and</p>Formula:C24H27Cl3FN5O3Purity:99.13% - >99.99%Color and Shape:SolidMolecular weight:558.86Canertinib dihydrochloride
CAS:<p>Inhibitor of EGFR, HER2 and HER4 tyrosine kinases</p>Formula:C24H25ClFN5O3·2HClPurity:Min. 95%Molecular weight:558.86





